A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma

Maeve A. Lowery; Kenneth H. Yu; David Paul Kelsen; James J. Harding; John S. Bomalaski; Danielle C. Glassman; Christina M. Covington; Robin Brenner; Ellen Hollywood; Adalberto Barba; Amanda Johnston; Kay Chia-Wei Liu; Xiaoxing Feng; Marinela Capanu; Ghassan K. Abou-Alfa; Eileen M. O'Reilly

doi:10.1002/cncr.30897

A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma

Cancer ◽

10.1002/cncr.30897 ◽

2017 ◽

Vol 123 (23) ◽

pp. 4556-4565 ◽

Cited By ~ 21

Author(s):

Maeve A. Lowery ◽

Kenneth H. Yu ◽

David Paul Kelsen ◽

James J. Harding ◽

John S. Bomalaski ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Phase 1 ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

A Phase 1 Study of Gemcitabine / Nab-Paclitaxel / S-1 (GAS) Combination Neoadjuvant Chemotherapy for Patients with Locally-Advanced Pancreatic Adenocarcinoma

Gastroenterology ◽

10.1016/s0016-5085(17)34163-x ◽

2017 ◽

Vol 152 (5) ◽

pp. S1250

Author(s):

Naru Kondo ◽

Yoshiaki Murakami ◽

Kenichiro Uemura ◽

Takeshi Sudo ◽

Yasushi Hashimoto ◽

...

Keyword(s):

Neoadjuvant Chemotherapy ◽

Pancreatic Adenocarcinoma ◽

Phase 1 ◽

Locally Advanced ◽

Phase 1 Study ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

The Phase 1 Study of Concurrent Chemoradiation Therapy With Gemcitabine and Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Adenocarcinoma Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.510 ◽

2016 ◽

Vol 96 (2) ◽

pp. S205

Author(s):

T. Ioka ◽

K. Katayama ◽

R. Takada ◽

N. Fukutake ◽

K. Ohkawa ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Phase 1 ◽

Locally Advanced ◽

Chemoradiation Therapy ◽

Concurrent Chemoradiation ◽

Phase 1 Study ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma ◽

Concurrent Chemoradiation Therapy

Download Full-text

Survival Outcome of a Phase 1 Trial: Hypofractionated Stereotactic Body Radiation Therapy Concurrent With Nelfinavir Following Gemcitabine and 5FU in Patients With Locally Advanced Pancreatic Adenocarcinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.05.757 ◽

2014 ◽

Vol 90 (1) ◽

pp. S203

Author(s):

C. Lin ◽

A.R. Sasson ◽

Q.P. Ly ◽

J.K. Schwarz ◽

C. Are ◽

...

Keyword(s):

Radiation Therapy ◽

Pancreatic Adenocarcinoma ◽

Stereotactic Body Radiation Therapy ◽

Phase 1 ◽

Locally Advanced ◽

Survival Outcome ◽

Phase 1 Trial ◽

Stereotactic Body Radiation ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3274-0 ◽

2017 ◽

Vol 79 (4) ◽

pp. 775-781 ◽

Cited By ~ 12

Author(s):

Naru Kondo ◽

Yoshiaki Murakami ◽

Kenichiro Uemura ◽

Takeshi Sudo ◽

Yasushi Hashimoto ◽

...

Keyword(s):

Neoadjuvant Chemotherapy ◽

Pancreatic Adenocarcinoma ◽

Phase 1 ◽

Locally Advanced ◽

Phase 1 Study ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

COMPARISON OF DIAGNOSTIC GAINS BY NEXT-GENERATION PROFILING, CONVENTIONAL CYTOLOGY AND HISTOLOGY IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA FOLLOWING EUS-GUIDED BIOPSY

10.1055/s-0040-1704665 ◽

2020 ◽

Author(s):

S Carrara ◽

L Laghi ◽

S Giulia ◽

M Di Leo ◽

L Lamonaca ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Next Generation ◽

Conventional Cytology ◽

Guided Biopsy ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

P-163 Real-world outcomes of cisplatin, capecitabine and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first-line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma

Annals of Oncology ◽

10.1016/j.annonc.2021.05.218 ◽

2021 ◽

Vol 32 ◽

pp. S155

Author(s):

N. Waldron ◽

N. Hitchen ◽

S. Deva ◽

G. Rivalland ◽

M. Findlay ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Real World ◽

Palliative Treatment ◽

Locally Advanced ◽

First Line ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancreatic adenocarcinoma

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2021.100342 ◽

2021 ◽

Vol 27 ◽

pp. 100342

Author(s):

Robin Park ◽

Mohammed Al-Jumayli ◽

Kirk Miller ◽

Azhar Saeed ◽

Anwaar Saeed

Keyword(s):

Pancreatic Adenocarcinoma ◽

Wild Type ◽

Advanced Pancreatic Adenocarcinoma ◽

Exon 19

Download Full-text

Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma

Acta Oncologica ◽

10.3109/0284186x.2015.1004367 ◽

2015 ◽

Vol 54 (7) ◽

pp. 979-985 ◽

Cited By ~ 96

Author(s):

Eric A. Mellon ◽

Sarah E. Hoffe ◽

Gregory M. Springett ◽

Jessica M. Frakes ◽

Tobin J. Strom ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Induction Chemotherapy ◽

Stereotactic Body Radiotherapy ◽

Locally Advanced ◽

Long Term Outcomes ◽

Borderline Resectable ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Neoadjuvant gemcitabine, S-1, and intensity-modulated radiotherapy (IMRT) in patients with locally advanced pancreatic adenocarcinoma (PDAC)

Pancreatology ◽

10.1016/j.pan.2016.06.172 ◽

2016 ◽

Vol 16 (4) ◽

pp. S46

Author(s):

Yuichi Hosokawa ◽

Yuichi Nagakawa ◽

Yatsuka Sahara ◽

Chie Takishita ◽

Tetsushi Nakajima ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Intensity Modulated Radiotherapy ◽

Intensity Modulated ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Dose-volume Analysis of Predictors for Gastrointestinal Toxicity after Radiotherapy and Concurrent Full-dose Gemcitabine for Locally Advanced Pancreatic Adenocarcinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.1676 ◽

2011 ◽

Vol 81 (2) ◽

pp. S169-S170 ◽

Cited By ~ 1

Author(s):

J. Huang ◽

J.M. Roberson ◽

H. Ye ◽

D. Yan

Keyword(s):

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Gastrointestinal Toxicity ◽

Volume Analysis ◽

Full Dose ◽

Dose Volume ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text